Trial Profile

Effects of LMWH Versus Dabigatran on Platelet Aggregation in Patients With Stable Coronary Artery Disease

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 13 Jul 2017

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dabigatran etexilate (Primary) ; Enoxaparin sodium
Indications Stroke; Thromboembolism; Venous thromboembolism
Focus Pharmacodynamics

Most Recent Events

28 Apr 2016 Study design changed from randomised,cross over to Non-randomised and single group also dosage of study drugs modified
15 Dec 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
24 Mar 2015 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com